Stock Information
Bicara Therapeutics Inc (BCAX)
Ticker Symbol: BCAX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,500.51 mil
Piotroski score: 1
PE Ratio: N/A
EPS (TTM): -2.5225
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -32.49%
Latest News
-
Bicara Therapeutics Inc. (BCAX) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Wed, May 13, 2026 3:00 PM
-
Transcript : Bicara Therapeutics Inc. Presents at Bank of America Global Healthcare Conference 2026, May-13-2026 09
Wed, May 13, 2026 1:20 PM
-
Bicara Therapeutics announces inducement grant under Nasdaq Listing Rule 5635(c)(4)
Wed, May 13, 2026 9:24 AM
-
Goldman Sachs Maintains Neutral on Bicara Therapeutics, Raises Price Target to $18
Tue, May 12, 2026 1:51 PM
-
Morgan Stanley Maintains Overweight on Bicara Therapeutics, Raises Price Target to $37
Tue, May 12, 2026 12:08 PM
-
Bicara Therapeutics Inc. Announces Executive Changes
Mon, May 11, 2026 3:35 PM
-
Guggenheim Initiates Coverage On Bicara Therapeutics with Buy Rating, Announces Price Target of $42
Mon, May 11, 2026 2:38 PM
-
Bicara Therapeutics (NASDAQ:BCAX) Q1 2026 Results Highlight Clinical Progress as EPS Misses Estimates
Mon, May 11, 2026 12:23 PM
-
Bicara Therapeutics Inc. (BCAX) Q1 2026 Earnings Call Transcript
Mon, May 11, 2026 12:00 PM
-
Transcript : Bicara Therapeutics Inc., Q1 2026 Earnings Call, May 11, 2026
Mon, May 11, 2026 11:50 AM
Key Financials
Financial data not available
